
It is becoming increasingly evident that zzso are dependent on a number of altered molecular pathways and can develop diverse mechanisms of resistance to therapy with single zzso zzso combination regimens may provide the best hope for effective therapies with durable zzso Despite zzso data to support this notion, there are many challenges to the development of targeted combinations including scientific, economic, legal, and regulatory zzso A discussion of these challenges and identification of models and best practices are presented with intent of aiding the research community in addressing real and perceived barriers to the development of combination therapies for zzso 

